Dirk Loeffert
Dirk is co-founder of BIOMILLENIA and a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialisation. After obtaining his Ph.D. in molecular genetics and immunology from the University of Cologne, Dirk joined QIAGEN where he was instrumental in building several new product portfolios at QIAGEN, such as QIAGENs enzyme and assay product portfolios. He represented in his former function at QIAGEN global product development as VP, Global Head of Product Development Life Sciences. In 2014, Dirk moved to Paris, France where he co-founded with scientific founders Dave Weitz (Harvard University, Cambridge), Rob Nicol (BROAD Institute, Cambridge) and Andrew Griffiths and Jerome Bibette (both ESPCI Paris, France) BIOMILLENIA.
David Tyrrell
David’s experience in skincare has spanned over 15 years. During his tenure at Kimberly-Clark he held positions in Corporate Research, New Product Development and Technology Scouting & Alliance Management. He has been active in identifying a variety of consumer and medical device technologies and products for in-licensing and led international research efforts in the biological characterization of naturally sourced skincare ingredients. David has a BS in Chemistry and a PhD in Biochemistry.
